Company Specified “Turnover increased by 9% to 41.5 million euros in the first half of the 2021-2022 financial year. This first semester was marked by strong business momentum and new SaaS signatures throughout its range. SaaS signatures were € 2.3 million, up 98% from the first half of the previous fiscal year and 72% higher than the pre-crisis level (first half of 2019/2020). By the end of September 2021, the Generics Group had reached ஐ 5.6 million worth of EPIDTA, up 3% from the first half of the previous year. The EBITDA margin is almost constant at 13.5% (14.2% in the first half of 2020/2021).”
Comment on this news and company strategy with my guest Jean-Charles Deconninck Chairman of the Generics Group Management Board.
You are interested in the generics group, Find out all the interviews that have already aired on Internet TV through this link: Generics videos
About the Generics team
Generics Group is a joint venture chain specialist in more than 60 countries, thanks to a network of its subsidiaries and its partners. Its SaaS solutions are used by nearly 6,000 companies worldwide. The group’s 800 employees support customers such as Carrefour, Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the digital transformation of their supply chain on a daily basis. Its joint venture Generics Supply Chain Hub helps companies keep their promises to their customers. It integrates the capabilities of activating body flows, eliminating information flow, joint management of processes and connecting companies with all their partners in real time. The Generics Supply Chain Hub is aimed at all players in the supply chain: manufacturers, logistics providers (3PL / 4PL) and distributors. Founded in France in 1990, the company is listed on the Euronext Paris Stock Exchange, C (ISIN: FR0010501692). Learn more: www.generixgroup.com